| Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw N Raje, SB Woo, K Hande, JT Yap, PG Richardson, S Vallet, N Treister, ... Clinical Cancer Research 14 (8), 2387-2395, 2008 | 165 | 2008 |
| A Phase 1 Trial of Lenalidomide (REVLIMID®) with Bortezomib (VELCADE®) in Relapsed and Refractory Multiple Myeloma. P Richardson, R Schlossman, N Munshi, D Avigan, S Jagannath, ... Blood, The Journal of the American Society of Hematology 106 (11), 365-365, 2005 | 55 | 2005 |
| A Multicenter Phase II Trial of Bortezomib in Patients with Previously Untreated Multiple Myeloma: Efficacy with Manageable Toxicity in Patients with Unexpectedly High Rates of … P Richardson, A Chanan-Khan, R Schlossman, N Munshi, P Wen, ... Blood, The Journal of the American Society of Hematology 106 (11), 2548-2548, 2005 | 40 | 2005 |
| Leveling evidence-based practice across the nursing curriculum K Hande, CT Williams, HM Robbins, BB Kennedy, T Christenbery The Journal for Nurse Practitioners 13 (1), e17-e22, 2017 | 38 | 2017 |
| Phase II Trial of Single Agent Bortezomib (VELCADE®) in Patients with Previously Untreated Multiple Myeloma (MM). PG Richardson, A Chanan-Khan, RL Schlossman, NC Munshi, P Wen, ... Blood, The Journal of the American Society of Hematology 104 (11), 336-336, 2004 | 32 | 2004 |
| Navigating DNP student needs: Faculty advising competencies and effective strategies for development and support K Hande, L Beuscher, T Allison, J Phillippi Nurse Educator 42 (3), 147-150, 2017 | 19 | 2017 |
| phase I study of the safety and efficacy of bortezomib (Velcade) in combination with CC-5013 (Revlimid) in relapse and refractory multiple myeloma (MM): the revel study PG Richardson, R Schlossman, N Munshi, D Avigan, S Jagannath, ... Haematologica 90 (suppl 1), 26, 2005 | 13* | 2005 |
| Phase I Clinical Trial of Oral Administration of the Histone Deacetylase (HDAC) Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Relapsed/Refractory Multiple … P Richardson, RL Schlossman, CS Mitsiades, NC Munshi, K Colson, ... Blood 104 (11), 1503, 2004 | 11 | 2004 |
| Clinical, Radiographic, and Biomarker Characterization of Multiple Myeloma Patients with Bisphosphonate Associated Osteonecrosis of the Jaw. N Raje, SB Woo, K Hande, JT Yap, PG Richardson, S Vallet, N Treister, ... Blood, The Journal of the American Society of Hematology 108 (11), 3591-3591, 2006 | 1 | 2006 |
| Osteonecrosis of the jaw in multiple myeloma patients. N Raje, SB Woo, K Hande, JT Yap, PG Richardson, S Vallet, N Treister, ... HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 92 (6), 216-216, 2007 | | 2007 |
| Osteonecrosis of the jaw and bisphosphonates SB Woo, K Hande, PG Richardson New England Journal of Medicine 353 (1), 100-100, 2005 | | 2005 |
| 95. doi: 10.1158/1078-0432 N Raje, SB Woo, K Hande, JT Yap, PG Richardson, S Vallet, N Treister CCR-07-1430, 0 | | |
Christopher Ty WilliamsAssociate Professor of Nursing, Vanderbilt UniversityVerified email at vanderbilt.edu
